Solicitation Amendment W81K0226QA0150002 SF 30.pdf

PDF 4 MB Posted

Attached to
Radiopharmaceutical Laboratory Services (RLS) MAMC
Solicitation number
W81K0226QA015
Issued by

About this file

This is Amendment 0002 to Solicitation W81K0226QA015, issued by W81K02 (W40M MRCO Pacific Medical Readiness Center of the Pacific) on January 21, 2026. The amendment extends the response due date from January 15, 2026 to January 23, 2026 at 10am Pacific Time. The solicitation seeks pharmaceutical and medical supply services, specifically radiopharmaceuticals and related materials for medical readiness support.

The salient characteristics have been revised to remove the Joint Commission accreditation requirement while maintaining other critical requirements. The contractor must use only FDA-approved materials and sources, comply with USP 825 standards, provide 24/7 customer support including weekends and non-business hours, deliver medications under urgent (24-hour) and STAT (after-hours, 2pm-4am) timelines, and offer safe delivery services for radioactive materials. The solicitation requires supply of numerous radiopharmaceuticals including various Tc99m compounds (Pertechnetate, HDP, Pyrophosphate, MDP, DTPA, Sulfur Colloid, MAA, MAG3, Mebrofenin, Myoview, Sestamibi, Nephroscan) in specified activities, iodine-based compounds (I-123 and I-131), Indium-111 compounds, Heparin, Kinevac/Sincalide, and WBC collection kits. Offerors must acknowledge receipt of this amendment prior to the extended deadline to avoid rejection.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended. is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing items 8 and 15, and returning copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER.

If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NUMBER AS DESCRIBED IN ITEM 14.

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER

NUMBER IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

15C. DATE SIGNED 16B. UNITED STATES OF AMERICA

(Signature of Contracting Officer)

16C. DATE SIGNED

Previous edition unusable STANDARD FORM 30 (REV. 11/2016) Prescribed by GSA FAR (48 CFR) 53.243

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE OF PAGES

2. AMENDMENT/MODIFICATION NUMBER 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUISITION NUMBER 5. PROJECT NUMBER (If applicable)

6. ISSUED BY CODE 7. ADMINISTERED BY (If other than Item 6) CODE

8. NAME AND ADDRESS OF CONTRACTOR (Number, street, county, State and ZIP Code) (X) 9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED (SEE ITEM 11)

10A. MODIFICATION OF CONTRACT/ORDER NUMBER

10B. DATED (SEE ITEM 13)

CODE FACILITY CODE

SF 30 BLOCK 14 CONTINUATION PAGE

SUMMARY OF CHANGES

Solicitation/Contract Form Continuation

The following changes have been made:

INFORMATION FROM TO

Response Due Date 15 Jan 2026 23 Jan 2026

Continuation of Description

Miscellaneous text in this section has been modified to:

Salient Characteristics

- Shall use only FDA approved materials and sources

- Shall be Joint Commission accredited

- Shall comply with USP 825 standards

- Shall be able to support "round the clock" customer support

- Shall have the ability to deliver support during weekends and non-business hours

- Shall be able to deliver medications under urgent and STAT timelines (Urgent would be within 24hrs and STAT would be after hours, between 2pm and 4 am).

- Shall offer safe and responsible delivery services in transporting radioactive material

W81K0226QA0150002

- Shall provide the following medications upon request:

- Tc99m Pertechnetate -up to 25 mCi

- Tc99m Pertechnetate (bulk)-price per mCi

- Tc99m HDP up to 25mCi

- Tc99m Pyrophosphate-up to 25 mCi

- Tc99m MDP-up to 25 mCi

- Tc99m DTPA -up to 25mCi

- Tc99m DTPA 26-40mCi

- Tc99m Sulfur Colloid-up to 8 mCi

- Tc99m MAA -up to 7mCi

- Tc99m MAA Low Particles <200K Particles

- Tc99m Filtered Sulfur Colloid per mCi

- Tc99m MAG3-up to 10mCi

- Tc-99m Mebrofenin - up to 10mCi

- Tc99m Myoview-up to 30 mCi

- Tc99m Sestamibi-up to 30mCi

- Tc99m Nephroscan (DMSA) - up to 5 mCi

- UltraTag Kit per vial

- I-123 NaI caps per 100uCi cap

- I-123 NaI caps per 200uCi cap

- I-123 NaI Compounded cap per mCI

- In-111 DTPA per 1.5mci vial

- In-111 Labeled WBC

- I-131 Tx cap First mCi

- I-131 Tx cap ea. additional mCi

- Heparin 1000u/ml

- Kinevac / Sincalide per vial

- WBC collection kit

IDCode: J
Page: 1
Pages: 4
AmendNo: 0002
EffDate: 21 JAN 2026
ReqNo:
ProjNo:
IssCode: W81K02
AdmCode:
IssuedBy: W40M MRCO PACIFIC

MEDICAL READINESS CONTR OFC PACIFIC, BLDG 339 CLARK ROAD

FORT SHAFTER, HI 96858-5098

UNITED STATES

CINDY MEANS, EMAIL: CINDY.J.MEANS.CIV@HEALTH.MIL TELEPHONE: 360-486-0719

AdminBy:

SCD: PAS:

ContractorNameAdd:
Code:
FacCode:
SolChg: 1
SolNo: W81K0226QA015
SolDate: 06 JAN 2026
AwardChg: Off
AwardNo:
AwardDate:
Amended: 1
OffrExt: 1
OffrNoEx: Off
NoCopies: 0
ApprData: SEE CONTINUATION
ChgeOrd: Off
ChgeOrder:
Modify: Off
SuppAgre: Off
SuppAuth:
ModOthr: Off
OthrSpec:
NoReq: Off
Require: Off
Copies:
Descript: The solicitation is amended to remove the Salient Characteristics removing the requirement to be Joint Commission accredited. The closing date is also amended to 10am Pacific Time on January 23rd 2026.
ContNameTitle:
CoNameTitle: SCOTT BARR
ContDate:
CODate: 21 JAN 2026

File details come from the government source that posted it. Updated .